G-protein-coupled estrogen receptor-1 (GPER) [1] |
Ga Binding Protein [1] |
GABA [1] |
Gabapentin [1] |
Gabra6 Gene [1] |
Gabra6 Protein, Human [1] |
Gadolinium oxide nanocuboides [1] |
Gain-of-function [1] |
Galactomannase [1] |
Galactose [1] |
Galangin [1] |
garlic [1] |
Gastrointestinal Hemorrhage [1] |
Gaucher Disease (GD) [1] |
GC-MS [1] |
GC�MS [1] |
Gene [3] |
gene amplification [1] |
Gene Deletion [1] |
Gene delivery [1] |
Gene editing [1] |
Gene Expression [4] |
Gene Expression Regulation [1] |
Gene Frequency [8] |
Gene Interaction [1] |
Gene Locus [7] |
Gene Mapping [1] |
Gene Mutation [2] |
gene mutation [1] |
gene silencing [1] |
Gene therapy [2] |
gene therapy [1] |
Gene variants [1] |
Gene Variants, [1] |
gene-gene interactions [1] |
Generalized Epilepsy [3] |
Genes [1] |
Genetic Analysis [2] |
Genetic Association [10] |
genetic association [3] |
Genetic Counseling [1] |
Genetic diseases [2] |
Genetic Disorder [2] |
genetic epidemiology [1] |
Genetic Generalized Epilepsy [1] |
Genetic Heterogeneity [1] |
Genetic heterogeneity [1] |
Genetic Linkage [2] |
Genetic Marker [1] |
genetic marker [1] |
genetic models [1] |
genetic modifiers [1] |
Genetic Polymorphism [4] |
Genetic polymorphism [1] |
Genetic polymorphisms [1] |
Genetic Predisposition [4] |
Genetic Predisposition To Disease [1] |
Genetic Risk [4] |
Genetic Screening [1] |
Genetic Susceptibility [4] |
genetic susceptibility [1] |
Genetic Variability [6] |
Genetic variant [1] |
genetic variant [1] |
Genetic variants [1] |
Genetic Variation [3] |
Genetics [4] |
genetics [3] |
Genipin [1] |
Genom [1] |
Genome Analysis [1] |
genome editing [2] |
genomewide association [1] |
Genomic alterations [1] |
Genomic Alterations, [1] |
genomic DNA; hemoglobin F; hemoglobin gamma chain; hemoglobin F; hemoglobin gamma chain; adolescent; adult; Article; blood transfusion; controlled study; disease severity; gene; gene expression; gene frequency; genetic association; genetic polymorphism; genetic variability; genotype; growth retardation; hemoglobin blood level; human; major clinical study; onset age; sickle cell anemia; splenectomy; thalassemia major; Xmn1 gene; allele; Anemia, Sickle Cell; beta-Thalassemia; child; female; geneti [1] |
Genomics [1] |
genomics [1] |
Genotype [8] |
genotype [1] |
Genotype Phenotype Correlation [1] |
Genotypes [1] |
Germline variations [1] |
Gerotarget [1] |
gestational diabetes [1] |
glass transition [1] |
Glial cells [1] |
gliflozin [1] |
Gliflozins [1] |
glioblastoma [1] |
Glioma [1] |
Global Burden of Disease [2] |
global disease burden [2] |
Global Health [2] |
global health [2] |
Global hypomethylation [1] |
GLP-1 [1] |
GLP-1RAs [1] |
Glucose [1] |
Glucose Blood Level [2] |
Glucuronosyltransferase [1] |
Glutamate [1] |
Glutamate Decarboxylase 65 [1] |
Glutamate Decarboxylase 67 [1] |
Glutathione [1] |
glutathione [1] |
Glutathione Peroxidase [1] |
glyceraldehyde 3 phosphate dehydrogenase [1] |
Glycolysis [1] |
Glycosylation [1] |
Glycylcysteinylcysteine [1] |
Gnflammatory markers [1] |
Gonadal hormone [1] |
gonadotropin [1] |
Goniothalamus wynaadensis Bedd [1] |
Government Regulation [1] |
GPx1−/−, P47phox−/−) [1] |
Granulocyte-colony stimulating factor [1] |
Granulocyte-colony stimulating factor-receptors [1] |
Granulomatosis with polyangiitis [1] |
granulomatosis with polyangiitis [1] |
Granulomatosis with polyangiitis (GPA) [1] |
Graphene [1] |
Growth disorders [1] |
Growth factors [1] |
growth regulation [1] |
growth retardat [1] |
GSA (Global Screening Array) [1] |
GSK-3? [1] |
Guanine [1] |
Gut microbiota [1] |
gut microbiota [1] |
Gut-lung axis [1] |
GWAS [2] |
H3K27 [1] |
H<sub>2</sub>S [1] |
Haloperidol [1] |
haloperidol [1] |
Haploinsufficiency [1] |
Haplotype [5] |
Haplotypes [1] |
HbA1c [1] |
HD- Huntington's disease [1] |
HDAC functions [1] |
HDAC inhibitors [1] |
HDAC knockout study [1] |
Headache [2] |
Health Care Cost [1] |
Health Care Facility [1] |
Health Care System [1] |
Health Center [1] |
Health Risk [1] |
Health Service [1] |
health survey [1] |
Healthcare [1] |
Heart failure [1] |
heart function [1] |
Heart Ventricle Hypertrophy [1] |
Heat Shock Protein 70 [1] |
Heat Shock Protein 90 [1] |
Hedgehog [1] |
Hemagglutination [1] |
hemagglutination [1] |
Hematological [1] |
Hemithioindigos [1] |
hemoglobinopathy [1] |
Hepatic injury [1] |
Her2 [1] |
HER2 Overexpression [1] |
HER2 positive breast cancer [1] |
HER2-positive breast cancer [1] |
herbal medicines [1] |
herbicides [1] |
Heritability [1] |
heritability [1] |
Heterocyclic [2] |
Heterocyclic compounds [1] |
Heterozygote [1] |
High Density Lipoprotein Cholesterol [2] |
High throughput technologies [1] |
Hindi [1] |
Hip [1] |
Hip Circumference [1] |
Hippo [1] |
Hippocampus [1] |
Histological analysis [1] |
Histone [1] |
Histone deacetylase [1] |
Histone deacetylases [3] |
Histone Modification [1] |
Histopathology [3] |
Hla Dq2 Antigen [1] |
Hla Dq8 Antigen [1] |
HLA genes [1] |
Hla Typing [1] |
Homeostasis [1] |
Homeostasis Model Assessment For Beta Cell Function [1] |
Homeostasis Model Assessment Insulin Resistance [1] |
homing [1] |
Homocysteine [3] |
Homologous recombination [1] |
Hum [1] |
Human [24] |
human [6] |
Human Cell [3] |
human cell [1] |
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer [1] |
Human Genetics [1] |
human monkeypox (HMPX) [1] |
human tissue [1] |
Humans [7] |
Huntington's disease [4] |
Huntington�s disease [4] |
Huntington�s disease (HD) [1] |
Huntington�s Disorder [1] |
Hybridization [1] |
Hydrogen peroxide [1] |
hydroxymethylglutaryl coenzyme A reductase kinase [1] |
Hyper-phosphorylated Tau [1] |
hyperactivity [1] |
Hyperalgesia [1] |
Hypercoagulability [1] |
Hyperglycaemia [1] |
Hyperglycemia [1] |
hyperglycemia [2] |
Hyperhomocysteinemia [1] |
Hypotension [1] |
Hypoxia Inducible Factor 1Alpha [1] |
hypoxic condition [1] |
IBD [1] |
ID-Migraine [1] |
Idiopathic recurrent pregnancy loss [1] |
imidazole [2] |
imidazole drugs [1] |
Imine pyrazolopyrimidinone [1] |
Imine/amide-imidazole [1] |
Immobilization [1] |
Immune cells activation [1] |
Immunity [1] |
immunochip [1] |
immunochip association study [1] |
Immunocompetent Cell [1] |
Immunoglobulin Enhancer Binding Protein [1] |
Immunohistochemistry [1] |
immunohistochemistry [1] |
Immunologic agent [1] |
Immunological Antineoplastic Agent [1] |
Immunology [1] |
Immunomodulating Agent [1] |
Immunomodulation [2] |
immunomodulation [1] |
immunotherapy [1] |
In [1] |
in silico [2] |
In Vitro Study [2] |
in vitro study [1] |
In Vivo Stu [1] |
in vivo study [1] |
Inafm2 Gene [1] |
Indi [1] |
India [9] |
Indian [3] |
Indian herbs [1] |
Indian population [1] |
induced pluripotent stem cells [1] |
Inducible nitric oxide synthase [1] |
Infection [2] |
Infectious diseases [1] |
Infertility, Male [1] |
Infiltrating ductal carcinoma [1] |
Inflammation [12] |
inflammation [4] |
Inflammatory cascade [1] |
inflammatory markers [1] |
Informed consent [1] |
inhibitor [2] |
Inhibitor Of Apoptosis Protein [1] |
inhibitors [1] |
Innate Immunity [1] |
Inner Membrane [1] |
Insect Bioassay [1] |
Insulin [2] |
insulin dependent diabetes mellitus [1] |
Insulin Receptor [1] |
Insulin Receptor Substrate [1] |
Insulin Receptor Substrate 1 [1] |
Insulin Resistance [2] |
Insulin resistance [2] |
Insulin sensitivity [1] |
Insulin-like growth factors [1] |
Intellectual Impairment [1] |
Intellectual property rights [1] |
Inter-laboratory study [1] |
Interleukin 1Beta [1] |
Interleukin-1? [1] |
interleukins [1] |
internal validity [1] |
Interphase Chromosome Profiling [1] |
Intractable Epilepsy [1] |
intrinsic pathway [1] |
Intron [3] |
Invadopodia [1] |
Invasion [4] |
invasive ductal carcinoma [1] |
Investigational drug [1] |
Iodine [1] |
Ion channels [1] |
iPSC [1] |
IRE1 [1] |
Iron superoxide dismutase [1] |
Irs 1 [1] |
Irs1 Protein, Human [1] |
Ischemia/reperfusion [1] |
Ischemic preconditioning [1] |
Ischemic Stroke [2] |
Ischemic stroke [3] |
Isoflavone [2] |
IUGR [1] |
Japanese (People) [1] |
Joints [1] |
K/Na [1] |
Karyotype 46,Xy [1] |
kbp 5209 [1] |
Kcnq1 Protein, Human [1] |
keratoconus [1] |
Ki67 [1] |
KIBRA [1] |
Kibra [1] |
Kidney stone dissolution [1] |
Killer alga [2] |
kitchen [1] |
Kunitz-type protease inhibitor, plant [1] |
Kynurenine pathway [1] |
L-alanine [1] |
L-methionine [1] |
Labramia bojeri [1] |
Lamotrigine [1] |
Lapatinib [1] |
lapatinib [1] |
lead (Pb) [1] |
Lectin [1] |
lectin bioinformatics [1] |
Lectin like activity [1] |
Leigh [1] |
Leishmania donovani [1] |
Leucaena leucocephala galactomannan [1] |
leukemia [1] |
Life Expectancy [1] |
life expectancy [1] |
Life Style [1] |
lifestyle [1] |
Ligand [1] |
Linkage disequilibrium [1] |
Lipid [1] |
lipid diet [1] |
Lipid Metabolism [1] |
lipid metabolism [1] |
Lipid metabolisms [1] |
Lipogenesis [1] |
Liver [1] |
liver [1] |
Liver damage [1] |
Liver diseases [1] |
Liver function test [1] |
Liver functions [1] |
Liver tissue [1] |
LncRNA [2] |
lncRNA [2] |
lncRNA MIR503HG [1] |
LncRNAs [1] |
locus specific primers [1] |
Long COVID [1] |
Low Density Lipoprotein Cholesterol [2] |
Lung cancer [1] |
lung cancer [3] |
Lung diagnostics [1] |
Lung injury [1] |
Luteolin [1] |
luteolin [1] |
Lymphocyte Culture [1] |
Lyngbya [1] |
Lysosomal Storage Disorders (LSD) [1] |
M [1] |
Machine learning [1] |
macrocephaly [1] |
Macronutrients [1] |
macrophage polarization [1] |
macrophage targeting [1] |
macrophages [1] |
Magnetic nanoparticles [1] |
Magnetic resonance imaging [1] |
main protease [2] |
Major Clinical S [1] |
Major Clinical Study [9] |
major clinical study [1] |
Major depressive disorder [1] |
major depressive disorder [1] |
Malaria [1] |
Male [16] |
male [4] |
Male breast cancer [1] |
Male Infertility [1] |
male infertility [1] |
malignant neoplasm [1] |
Malnutrition [2] |
Malonaldehyde [1] |
Mammalian Target Of Rapamycin [1] |
Managed Care [1] |
management [1] |
Mannose [1] |
Marine alga [2] |
Marine algae [1] |
marketed drugs [1] |
mass spectrometry [1] |
Maternal factors [1] |
Maternal Uniparental Disomy of chromosome 7 [1] |
MCF-7 cell line [1] |
MD simulation [2] |
MDA-MB-157 cell line [1] |
Mda-Mb-231 Cell Line [1] |
MDAMB453 [1] |
Mean platelet volume [1] |
Measles Vaccine [1] |
measles vaccine [1] |
mechanism of action [1] |
Medical Research [1] |
Medical Society [1] |
Medicinal plant [1] |
Mediterranean diet [1] |
Melatonin 1 Receptor [1] |
Melittin [1] |
Memory [1] |
Mendelian randomization [1] |
Mendelian Randomization Analysis [1] |
Mendelian randomization analysis [1] |
MERS [1] |
Mesenchymal stem cells [1] |
mesenchymal stem cells [2] |
Messenger Rna [1] |
Messenger Rna Precursor [1] |
Meta Analysis [2] |
meta analysis [1] |
Meta Analysis (Topic) [1] |
Meta transcriptomics [1] |
Meta-analysis [7] |
meta-analysis [7] |
Meta-Analysis Asb3 Gene [1] |
Metabolic reprogramming [2] |
metabolic reprogramming [1] |
Metabolism [5] |
metabolism [2] |
Metagenomics [2] |
Metastasis [13] |
methenamine [1] |
Methionine [1] |
methionine [1] |
Methionine restriction [1] |
Methionine supplementation [1] |
methylation defects [1] |
Methyltransferase [1] |
methyltransferase [1] |
Mice (MnSODtg [1] |
micro RNAs [1] |
Microarrays [1] |
Microbial dynamics [1] |
Microbial dysbiosis [1] |
Microbiome [2] |
microbiome [2] |
Microcephaly [1] |
Microglia [1] |
microglia [1] |
Micronutrient [1] |
Micronutrients [1] |
Microrna [1] |
microRNA [1] |
Microrna 181A [1] |
Microrna 30C [1] |
microRNAs [2] |
Microvascular complications [2] |
Microwave irradiation [1] |
Middle Aged [2] |
Middle East [1] |
midgut [1] |
Migraine [2] |
migraine [2] |
Migration [1] |
Milrinone [1] |
milrinone [1] |
Minerals [1] |
Mir4686 Gene [1] |
Mirn181 Microrna, Rat [1] |
Mirn30 Microrna, Rat [1] |
miRNA [8] |
MiRNAs [1] |
miRNAs [4] |
Misfolding [1] |
Mito K<sub>ATP</sub> [1] |
Mito-miRs [1] |
Mitochondria [12] |
mitochondria [1] |
mitochondrial biogenesis [1] |
Mitochondrial changes [1] |
Mitochondrial dynamics [1] |
Mitochondrial Dysfunction [2] |
Mitochondrial dysfunction [4] |
mitochondrial dysfunction [1] |
Mitochondrial medicine [2] |
Mitochondrial miRNA [1] |
Mitochondrial Protein [1] |
Mitochondrial protein [1] |
mitogenesis [1] |
Mitophagy [2] |
Modulation [1] |
Molecular Diagnosis [1] |
Molecular docking [4] |
molecular docking [4] |
molecular dynamics [1] |
Molecular dynamics simulation [1] |
Molecular Genetics [1] |
Molecular mechanism [1] |
Molecular mechanisms [1] |
Molecular modeling [2] |
Molecular modelling [1] |
Molecular pathways [1] |
molecular pathways [1] |
Molecular weight [1] |
Monkeypox [2] |
monkeypox virus (MPXV) [1] |
Monogenic inherited epilepsies [1] |
MOPD type II [2] |
Moringa oleifera [1] |
mortality [1] |
Mouse [1] |
Movement disorders [1] |
moxifloxacin [1] |
MPV [1] |
MPXV pathophysiology [1] |
MRI [1] |
mRNA [1] |
mRNA vaccine [1] |
Mtnr1B Protein, Human [1] |
MTOR [1] |
mTOR [1] |
MTT [1] |
MTT assay [1] |
mubritinib [1] |
Mucormycosis [1] |
mucormycosis [1] |
Multifactor Dimensionality Reduction [1] |
Multiphoton Microscopy [1] |
Multiple Linear Regression Analysis [1] |
Multiple sclerosis [2] |
multiple sclerosis [1] |
Muscular dystrophy [1] |
Mutant [1] |
Mutant p53 [1] |
Mutation [1] |
mutation [1] |
Mutations [4] |
Myeloperoxidase [1] |
myeloperoxidase [1] |
myocardial hypertrophy [1] |
myocardial injury [1] |
Myoclonus Seizure [1] |
Myogenic progenitor [1] |
n [4 [3 chloro 4 (3 fluorobenzyloxy)anilino] 6 q [1] |
N-heterocycles [1] |
nAChR/Nrf2/HO-1 pathway [1] |
NADPH oxidase [1] |
NAFLD [1] |
Nano-carrier [1] |
Nanoformulation [1] |
Nanomaterials [1] |
Nanomedicine [2] |
Nanoparticle [1] |
Nanoparticles [5] |
nanoparticles [2] |
Nanosponges [1] |
Nanotheranostics [1] |
NASH [1] |
National Iodine Deficiency Disorders Control Programme [1] |
natural molecules [1] |
natural phytochemicals [1] |
natural plants [1] |
Natural product [1] |
Natural products [3] |
NCI-H1299 cell line [1] |
Necrosis [1] |
nephropathy [1] |
nephrotoxicity [1] |
nerolidol [1] |
Nerve Degeneration [2] |
nerve injury [1] |
NETosis [1] |
network pharmacology [1] |
Neurodegeneration [4] |
neurodegeneration [3] |
Neurodegenerative and cardiovascular diseases [1] |
Neurodegenerative diseases [2] |
Neurodegenerative disorder [1] |
Neurodegenerative disorders [1] |
neurodegenerative disorders [1] |
neurodevelopmental disorder [1] |
Neurofibrillary tangles [1] |
neurogenesis [1] |
Neuroimaging [1] |
Neuroinflamamation [1] |
Neuroinflammation [4] |
neuroinflammation [3] |
Neurological diseases [2] |
Neurological disorders [1] |
neuronal death [2] |
Neuronal injury [1] |
Neurons [1] |
neurons [1] |
Neuropathic pain [2] |
neuropathic pain [1] |
Neuroprotection [3] |
neuroprotection [3] |
neuroprotective effect [1] |
Neuroprotective effects [1] |
Neuropsychiatric diseases [1] |
neurotherapeutics [1] |
Neurotoxicity [1] |
Neurotransmission [1] |
neurotransmission [1] |
Neurotransmitters [1] |
neurotransmitters [1] |
Next Generation Sequencing [1] |
NF-kB [1] |
NF?B [1] |
NIDDCP [1] |
Nitric Oxide [1] |
Nitric oxide [3] |
NMDA receptor [1] |
Nociception [1] |
Non human [1] |
Non Insulin Dependent Diabetes Mellitus [4] |
non insulin dependent diabetes mellitus [2] |
Non-alcoholic Fatty Liver Disease [1] |
Non-alcoholic steatohepatitis [1] |
Non-Coding Rna [1] |
Non-coding RNA [1] |
Non-coding RNAs [2] |
non-dynamin GTPases [1] |
Non-HLA genes [1] |
Non-invasive imaging [1] |
non-syndromic hearing loss [1] |
Non-viral vectors [1] |
Non?coding RNA [1] |
nonalcoholic fatty liver [1] |
Nonalcoholic steatohepatitis [1] |
Nonhuman [1] |
nonhuman [2] |
Nonsense [1] |
Nonsteroid Antiinflammatory Agent [1] |
normoxic condition [1] |
North Africa [1] |
north Indians [1] |
noscapine [1] |
novel drug delivery [1] |
Novel missense alterations [1] |
Novel treatments [1] |
NRF-2 (Nuclear respiratory factor-2) [1] |
Nrf2/HO-1 [1] |
Nuclear Protein [1] |
Nucleotide Sequence [2] |
Nutrition [2] |
nutritional therapy [1] |
Obesity [5] |
obesity [2] |
Observational Study [1] |
Occupational hazard [1] |
Odds Ratio [1] |
odds ratio [1] |
Oligomycin [1] |
Omics [1] |
Onset Age [2] |
Optical coherence tomography [1] |
Oral-antidiabetic drugs [1] |
Orbital [1] |
Organelle crosstalk [1] |
organic semiconducting material [1] |
organic solar cell [1] |
organophosphate pesticides [1] |
origin recognition complex [1] |
Osteoporosis [1] |
osteoporosis [1] |
Outbreaks [1] |
overexpression/amplification [1] |
Oxidative and Nitrosative Stress [1] |
oxidative pressure [1] |
Oxidative Stress [5] |
Oxidative stress [18] |
oxidative stress [5] |
Oxidative stress markers [1] |
Oxidizing Agent [1] |
Oxidizing agent [1] |
OXPHOS [1] |
P53 [2] |
Pacific islands [1] |
Pain [1] |
Pancreas Islet Beta Cell [1] |
Pancreatic ?-cells [1] |
Pancreatic islet [1] |
Panic disorder [1] |
PAR-? [1] |
Parent- child trio study [1] |
Parent-child trio study [1] |
Parkinson's disease [5] |
Parkinson�s [1] |
Parkinson�s disease [2] |
Parkinson�s diseases (PD) [1] |
Patent [2] |
Pathogenesis [4] |
pathogenesis [1] |
pathogenic genetic variants [1] |
Pathogens [1] |
Pathology [1] |
pathology [1] |
Pathway [1] |
pathway [1] |
Patient-related risk factors [1] |
PCNT [2] |
PCOS [3] |
PCR [1] |
Pediococcus acidilactici BD16 [1] |
PEITC [2] |
Peltophorum dubium; [1] |
Pentylenetetrazole [1] |
pentylenetetrazole [1] |
Peptide [1] |
Peptides [1] |
pericentrin [1] |
Perinatal Period [1] |
PERK [1] |
Peroxidase [1] |
Peroxisome Proliferator Activated Receptor Gamma [1] |
Peroxynitrite [1] |
Peroxynitrous acid [1] |
Personalized medicine [1] |
Pexacerfont [1] |
pharmaceutical therapies [1] |
Pharmacodynamics [3] |
Pharmacogenetics [1] |
pharmacogenetics [1] |
Pharmacogenomics [1] |
pharmacogenomics [1] |
pharmacokinetic parameters [1] |
Pharmacokinetics [2] |
Pharmacological Activity [1] |
pharmacological activity [1] |
Pharmacological effects [1] |
pharmacology [1] |
Pharmacotherapy [1] |
Phenolics [1] |
phenotype [2] |
Phenytoin [2] |
phosphodiesterase [1] |
phosphodiesterase 4D; phosphodiesterase IV; platelet derived growth factor; small interfering RNA; unclassified drug; PDE4D protein, human; phosphodiesterase IV; arterial wall thickness; blood brain barrier; blood vessel permeability; brain ischemia; cardioembolic stroke; cell proliferation; ethnic difference; female; gene; gene frequency; genetic association; genetic epidemiology; genetic predisposition; genetic variability; genotype; haplotype; human; immunoreactivity; ligand binding; magnetic [1] |
phosphodiesterase inhibitor [1] |
phosphodiesterase IV inhibitor [1] |
phosphodiesterase V inhibitor [1] |
Phosphorylated tau [1] |
Phosphotransferase [1] |
phylogeny [1] |
physical activity [1] |
physical trauma models [1] |
phyto-pathogens [1] |
Phytochemical screening [1] |
Phytochemical, TMPRSS2 [1] |
Phytochemicals [3] |
phytoconstituents [1] |
PI3k/Akt [1] |
Pictet-Spengler reaction [1] |
Pictet-spengler reaction [1] |
Pictet-Spenglerase enzymes [1] |
Pictet-spenglerase enzymes [1] |
PIK3CA [1] |
Pirna [1] |
piroxicam [1] |
plant constituents [1] |
Plant Extract [1] |
plant extract [1] |
Plant Extracts [1] |
plant leaf [1] |
Plant Leaves [1] |
Plant lectin [1] |
Plant protein [1] |
plant root [1] |
Plant Roots [1] |
plant stem [1] |
Plasmodium falciparum [1] |
Plastic pollution [1] |
platelet count [1] |
Platelets [1] |
PLGA [1] |
PNGR [1] |
Podosome [1] |
poliomyelitis vaccine [1] |
Poliovirus Vaccines [1] |
Pollutants [1] |
polyacrylamide gel electrophoresis [1] |
Polyacrylamide Gel Electrophoresis (PAGE) [1] |
Polycystic ovary syndrome (PCOS) [1] |
Polygenic risk score [1] |
Polyherbal formulation [1] |
Polymerase Chai [1] |
Polymerase Chain Reaction [1] |
polymerase chain reaction [1] |
Polymeric prodrug [1] |
Polymorphism [1] |
Polymorphism, Single Nucleotide [1] |
PolyPhen [1] |
Polyphenol [1] |
Polyphenols [2] |
Polysaccharides [1] |
Poor outcome [1] |
population genetics [1] |
Postmenopause [1] |
Potassium Channel Kcnq1 [1] |
Potential [1] |
power conversion efficiency [1] |
Pparg Gene [1] |
PRC2 [1] |
Pre Mrna Processing Factor 31 [1] |
pre-clinical [1] |
Prebiotics [1] |
prediction [1] |
Predictor Variable [1] |
Pregnancy [1] |
Pregnancy and fetal transmission [1] |
Prenatal Diagnosis [1] |
Preschool Child [1] |
Prevalence [1] |
prevalence [1] |
Prevention [1] |
Preventive Medicine [1] |
Prime MM/GBSA [1] |
Primordial dwarfism [1] |
Priority Journal [3] |
Probiotics [3] |
Prognosis [1] |
prognosis [1] |
Prognostic Assessment [1] |
Prognostic markers [1] |
progressive keratoconus [1] |
Proline [1] |
Prooxidant [1] |
Prostaglandin G2 [1] |
Prostaglandin H2 [1] |
Prostaglandin Synthase [1] |
prostate cancer [2] |
Protease activated receptor-2 [1] |
Proteases [1] |
Protective effects [1] |
Protein [1] |
protein analysis [1] |
Protein Binding [1] |
Protein Eor 1 [1] |
Protein Expression [1] |
protein expression [2] |
Protein folding [1] |
Protein Function [1] |
protein kinase [1] |
Protein Kinase Inhibitor [1] |
Protein kinase inhibitor [1] |
Protein P21 [1] |
Protein P53 [3] |
protein p53 [1] |
Protein Protein Interaction [1] |
protein purification [1] |
protein refolding [1] |
Protein targeting [1] |
Proteinase [1] |
protein�protein interaction [1] |
Proteome [2] |
Protocol [1] |
Protozoal protein [1] |
Psoriasis [1] |
psychological
stress [1] |
Pterostilbene [1] |
PTSD [1] |
public policy [1] |
Punjabi [1] |
Pyrazoles [1] |
Pyrazolo[1,5-c]quinazolines [2] |
pyridazine [1] |
Pyrimidines [1] |
Pyrimidinone derivative [1] |
PZ [1] |
Qatar [1] |
qRT-PCR [1] |
QSAR [1] |
quality adjusted life year [1] |
quality control [1] |
Quality-Adjusted Life Years [1] |
Quercetin [4] |
Quinazoline Derivative [1] |
Quinoline [1] |
Quinolinic acid [1] |
rabbit [1] |
Rare and common variants [1] |
rat [1] |
Rats [2] |
Rats, Sprague-Dawley [1] |
RDA [1] |
Reactivation [1] |
Reactive Nitrogen Species [2] |
Reactive Oxygen Metabolite [3] |
Reactive oxygen metabolite [1] |
Reactive Oxygen Species [1] |
Reactive oxygen species [2] |
Reactive Oxygen Species (ROS) [1] |
Reactive oxygen species and cancer [1] |
Rearranged during transfection [1] |
Receptor tyrosine kinase [2] |
Recombinant Cystatin 9 [1] |
Recommended daily allowance [1] |
Recovery [1] |
Recurrence [1] |
Redox Effector Factor 1 [1] |
Regional hypermethylation [1] |
registration [1] |
release [1] |
renal protection [1] |
replication [1] |
replication licensing factor Cdt1 [1] |
Resting-state fMRI [1] |
Restriction Fragment Length Polymorphism [2] |
Resveratrol [1] |
Retinitis Pigmentosa [1] |
Review [3] |
RFLP [1] |
Rheumatoid arthritis [2] |
Rhino [1] |
Rhino-orbito-cerebral mucormycosis [1] |
rhino-orbito-cerebral mucormycosis [1] |
Rho [1] |
Rho-0 Cells [1] |
Rho/ROCK pathway [1] |
Rice bran [1] |
Ring Chromosome [1] |
Ring Chromosome 22 [1] |
risk assessment [2] |
Risk Factor [1] |
risk factor [2] |
Risk Factors [1] |
Risk factors [1] |
RNA [1] |
RNA dependent RNA polymerase [2] |
RNA isolation [1] |
RNA sequencing [1] |
RNAi [1] |
ROCK [1] |
rolipram [1] |
ROS [5] |
Ros [1] |
Rosmarinic Acid [1] |
Rosmarinic acid [1] |
Rotenone [2] |
Rs20417 Variant [1] |
Rs721917 [1] |
ryanodine receptor [1] |
Safety genetically modified organisms [1] |
Salt [1] |
SAR [1] |
SARS CoV-2 [1] |
SARS-CoV-2 [7] |
SBBI [1] |
scaffold [1] |
schizophrenia [1] |
School Child [1] |
screening [1] |
Secondary complications [1] |
Secondary metabolites [1] |
seed sequences [1] |
Seizure [1] |
Selenium nanoparticles [1] |
Selenoproteins [1] |
sepsis [2] |
sequence analysis [1] |
Sequencing [2] |
Ser7Ala Polymorphism [1] |
SERCA pump [1] |
Serine proteinase inhibitor [1] |
Serine Proteinase Omi [1] |
Sesbania grandiflora [1] |
Sesquiterpenes [1] |
Severe acute respiratory syndrome coronavirus 2 [1] |
severe acute respiratory syndrome coronavirus-2 [1] |
SFTPD [2] |
SGLT-1 [1] |
SGLT2 inhibitors [2] |
SGLT2 protein [1] |
shared mechanisms [1] |
Sickle cell [1] |
Sickle cell anaemia [1] |
Sickle cell anemia (SCD) [1] |
sickle cell disease [1] |
SIFT [1] |
Signal transduction [1] |
signal transduction [1] |
Signaling [1] |
signaling [1] |
Signaling pathways [1] |
signaling pathways [1] |
Signalling pathways [3] |
sildenafil [1] |
Silver nanoparticles [1] |
Silver-Russell Syndrome [1] |
Silver-Russell syndrome [1] |
Silymarin [1] |
simulation [1] |
Sinapic acid [1] |
Single Nucleotide Polymorphis [1] |
Single Nucleotide Polymorphism [3] |
single nucleotide polymorphism [1] |
Single nucleotide polymorphisms (SNPs) [1] |
siRNA [1] |
Sirtuin [1] |
Sirtuin 1 [2] |
sirtuin 1 [1] |
Sitgmasterol [1] |
Small Interfering Rna [1] |
small molecules [1] |
small nuclear RNA [1] |
Smar1 Protein [1] |
SNP [1] |
SNPs [2] |
social status [1] |
Socioeconomics [1] |
solar energy [1] |
Solid dispersion [1] |
South and Central America [1] |
South Asian [2] |
Spices [1] |
Spike glycoprotein [1] |
spike glycoprotein [1] |
spike protein [3] |
Spine loss [1] |
Spontaneous Abortion [1] |
spontaneous abortions [1] |
Sprague Dawley rat [1] |
Sprague-Dawley rats [1] |
spray drying [1] |
standardization [1] |
statistical analysis [1] |
Statistical parame [1] |
Steatosis [1] |
Stem Cell Therapy [1] |
Stem cell therapy [1] |
Stemness potential [1] |
Steroidal alkaloids [1] |
steroidogenesis [2] |
Stilbene [1] |
Streptozocin [1] |
Streptozotocin [2] |
Stress [2] |
Stroke [1] |
stroke [2] |
stroke treatment [1] |
structural insights [1] |
Structure [1] |
structure [2] |
Structure activity relationship (SAR) [1] |
Superoxide [1] |
Superoxide Dismutase [4] |
Superoxide dismutase [1] |
supplemental oxygen [1] |
Survival [1] |
Survival index [1] |
Susceptibility [1] |
Susceptibility genes [1] |
susceptibility genes [1] |
Synapse [2] |
Synapsin [1] |
Synapsin Ii [1] |
synergism [1] |
synergistic action [1] |
synthesis and processing techniques [1] |
Systematic review [4] |
systematic review [3] |
tadalafil [1] |
TallyHO/JngJ mice [1] |
TAM receptors [1] |
tannins [1] |
Tardive dyskinesia [2] |
tardive dyskinesia [1] |
Tardive dyskinesia (TD) [1] |
Target gene [1] |
target genes [1] |
Targeted drug delivery [2] |
Tau hyperphosphorylation [1] |
Telangana [1] |
Telophase [1] |
Temozolomide [1] |
terminalia [1] |
Tetrahydro-?-carbolines [1] |
Tetrahydro-β-carbolines [1] |
Tetrahydroimidazopyridines [2] |
Tetrahydroisoquinoline [2] |
Therapeutic interventions [1] |
Therapeutic strategies [2] |
Therapeutic targets [1] |
Therapeutic tool [1] |
Therapeutics [5] |
therapeutics [1] |
Therapy [1] |
therapy [1] |
Thioredoxin [2] |
Thrombocyte Aggregation [1] |
Thymine [2] |
Thyroid [1] |
Thyroid disorders [1] |
Thyroid gland [1] |
time factor [1] |
Time Factors [1] |
tissue engineering [1] |
tissue microarray [1] |
TMPRSS2 [1] |
TNF-? [1] |
tobacco use [1] |
Toll Like Receptor 4 [1] |
Topoisomerase [1] |
Topoisomerase inhibition [1] |
Topoisomerase inhibitors [2] |
Total phenol [1] |
toxicity [1] |
Trace elements [1] |
Trans cinnamaldehyde [1] |
Transcription [2] |
Transcription Factor [2] |
transcription factor [1] |
Transcription Factor Daf 16 [1] |
Transcription Factor Fkhrl1 Caenorhabditis Elegans [1] |
Transcription Factor Foxo [1] |
Transcription Factor Nrf1 [1] |
Transcription Factor Pax8 [1] |
Transcription Factors [1] |
Transdermal [1] |
Transfection [1] |
transfection [1] |
Transfer RNA fragments [1] |
Transferrin [1] |
Transgenic [1] |
transmembrane protease serine 2 [1] |
Transmembrane serine protease 2 [1] |
Transpeptidase [1] |
transwell assay [1] |
Trastuzumab [2] |
trastuzumab resistance [1] |
Trastuzumab. [1] |
trauma [1] |
traumatic brain injury [1] |
Treatment [1] |
treatment [1] |
trend study [1] |
Triacylglycerol [2] |
Triazole [1] |
Triglyceride [1] |
Triple-negative breast cancer [1] |
Tropomyosin kinase receptors [1] |
Trypanosoma [1] |
Tryparedoxin [1] |
Tryparedoxin peroxidase [1] |
Tryptophan [1] |
Tryptophan metabolism [1] |
Tuberculosis [1] |
Tumor angiogenesis [1] |
Tumor growth [1] |
tumor invasion [1] |
Tumor Promoter [1] |
tumor suppressor [1] |
tumor suppressor p53 [1] |
Tumor Suppressor Protein [1] |
tumor suppressor protein [1] |
Tumor Suppressor Protein p53 [1] |
tumor xenograft [1] |
Tumorigenesis [1] |
Turbidometric analysis [1] |
Type 1 diabetes mellitus [1] |
Type 2 diabetes [4] |
type 2 diabetes [1] |
type 2 diabetes mellitus [1] |
Type-2 diabetes [1] |
type-2 diabetes [1] |
Tyro 3 [1] |
Ugt1A6 Gene [1] |
ulcerative colitis [1] |
Uncl [1] |
Unclassified Drug [7] |
Unclassified drug [3] |
unclassified drug [1] |
Unclassified Drug Biodegradation [1] |
Unfolded Protein Response [1] |
Unfolded protein response [1] |
uniparental disomy [1] |
Untranslated Rna [1] |
UPR [1] |
Upregulation [1] |
Uracil [1] |
utlity [1] |
UTX [1] |
Vaccination Coverage [1] |
vaccination coverage [1] |
Vaccine [1] |
Vaccines [2] |
validation [1] |
Valproic Acid [2] |
vardenafil [1] |
Variants [1] |
Vascular function [2] |
Vascular leakage [1] |
Vascular smooth muscle cells [1] |
Vegetarian [1] |
VEGF [1] |
Verucerfont [1] |
Very Low Density Lipoprotein [1] |
Very Low Density Lipoprotein Cholesterol [1] |
Vincamine [1] |
Viral vectors [1] |
Visual Acuity; [1] |
Vitamin [1] |
vitamin blood level [1] |
Vitamin D [1] |
vitamin D [1] |
Vitamin D Deficiency [1] |
vitamin D deficiency [3] |
vitamin D receptor [1] |
Vitamin D-binding protein [1] |
vitiligo [1] |
VOCs [1] |
Vulvovaginal candidiasis [1] |
wedelia [1] |
Wegener�s granulomatosis [1] |
weight drop model [1] |
Western blotting [1] |
WHO [2] |
Whole Exome Sequencing [1] |
Withania [1] |
Withania somnifera [2] |
Withania somnifera extract [1] |
Wonder material [1] |
zaprinast [1] |
Zebrafish [3] |
Zingiber roseum [2] |
Zingiberaceae [1] |
β -thalassemia [1] |